| UniProt ID | CDC16_HUMAN | |
|---|---|---|
| UniProt AC | Q13042 | |
| Protein Name | Cell division cycle protein 16 homolog | |
| Gene Name | CDC16 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 620 | |
| Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, spindle . Colocalizes with CDC27 to the centrosome at all stages of the cell cycle and to the mitotic spindle. | |
| Protein Description | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains.. | |
| Protein Sequence | MNLERLRKRVRQYLDQQQYQSALFWADKVASLSREEPQDIYWLAQCLYLTAQYHRAAHALRSRKLDKLYEACRYLAARCHYAAKEHQQALDVLDMEEPINKRLFEKYLKDESGFKDPSSDWEMSQSSIKSSICLLRGKIYDALDNRTLATYSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKELLESLPLSKLCNEEQELLRFLFENKLKKYNKPSETVIPESVDGLQENLDVVVSLAERHYYNCDFKMCYKLTSVVMEKDPFHASCLPVHIGTLVELNKANELFYLSHKLVDLYPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLEKTYGPAWIAYGHSFAVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNSKLAERFFSQALSIAPEDPFVMHEVGVVAFQNGEWKTAEKWFLDALEKIKAIGNEVTVDKWEPLLNNLGHVCRKLKKYAEALDYHRQALVLIPQNASTYSAIGYIHSLMGNFENAVDYFHTALGLRRDDTFSVTMLGHCIEMYIGDSEAYIGADIKDKLKCYDFDVHTMKTLKNIISPPWDFREFEVEKQTAEETGLTPLETSRKTPDSRPSLEETFEIEMNESDMMLETSMSDHST | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Ubiquitination | RLRKRVRQYLDQQQY HHHHHHHHHHHHHHH | 40.04 | 21890473 | |
| 21 | Ubiquitination | LDQQQYQSALFWADK HHHHHHHHHHHHHHH | 23.23 | 21890473 | |
| 28 | Ubiquitination | SALFWADKVASLSRE HHHHHHHHHHHCCCC | 31.77 | - | |
| 31 | Phosphorylation | FWADKVASLSREEPQ HHHHHHHHCCCCCCH | 29.84 | 27174698 | |
| 33 | Phosphorylation | ADKVASLSREEPQDI HHHHHHCCCCCCHHH | 34.84 | 27174698 | |
| 41 | Phosphorylation | REEPQDIYWLAQCLY CCCCHHHHHHHHHHH | 11.58 | 29978859 | |
| 48 | Phosphorylation | YWLAQCLYLTAQYHR HHHHHHHHHHHHHHH | 15.05 | 29978859 | |
| 50 | Phosphorylation | LAQCLYLTAQYHRAA HHHHHHHHHHHHHHH | 9.73 | 29978859 | |
| 53 | Phosphorylation | CLYLTAQYHRAAHAL HHHHHHHHHHHHHHH | 7.27 | 29978859 | |
| 60 | Ubiquitination | YHRAAHALRSRKLDK HHHHHHHHHHCHHHH | 3.52 | 21890473 | |
| 101 | Acetylation | DMEEPINKRLFEKYL CCCCCHHHHHHHHHH | 51.72 | 26051181 | |
| 101 | Ubiquitination | DMEEPINKRLFEKYL CCCCCHHHHHHHHHH | 51.72 | - | |
| 105 (in isoform 2) | Ubiquitination | - | 45.44 | 21890473 | |
| 105 (in isoform 3) | Ubiquitination | - | 45.44 | 21890473 | |
| 106 | Ubiquitination | INKRLFEKYLKDESG HHHHHHHHHHCCCCC | 48.85 | 21890473 | |
| 106 (in isoform 1) | Ubiquitination | - | 48.85 | 21890473 | |
| 109 | Ubiquitination | RLFEKYLKDESGFKD HHHHHHHCCCCCCCC | 57.25 | - | |
| 109 | Acetylation | RLFEKYLKDESGFKD HHHHHHHCCCCCCCC | 57.25 | 26051181 | |
| 112 | Phosphorylation | EKYLKDESGFKDPSS HHHHCCCCCCCCCCC | 60.71 | 22199227 | |
| 114 (in isoform 2) | Ubiquitination | - | 12.96 | 21890473 | |
| 114 (in isoform 3) | Ubiquitination | - | 12.96 | 21890473 | |
| 115 | Ubiquitination | LKDESGFKDPSSDWE HCCCCCCCCCCCCCC | 72.72 | 21906983 | |
| 115 (in isoform 1) | Ubiquitination | - | 72.72 | 21890473 | |
| 118 | Phosphorylation | ESGFKDPSSDWEMSQ CCCCCCCCCCCCCCH | 51.57 | 29083192 | |
| 119 | Phosphorylation | SGFKDPSSDWEMSQS CCCCCCCCCCCCCHH | 52.73 | 29083192 | |
| 124 | Phosphorylation | PSSDWEMSQSSIKSS CCCCCCCCHHHHHHH | 18.52 | 29083192 | |
| 126 | Phosphorylation | SDWEMSQSSIKSSIC CCCCCCHHHHHHHHH | 27.07 | 29083192 | |
| 129 | Ubiquitination | EMSQSSIKSSICLLR CCCHHHHHHHHHHHH | 39.85 | - | |
| 138 | Ubiquitination | SICLLRGKIYDALDN HHHHHHCCHHHHCCC | 31.49 | - | |
| 140 | Phosphorylation | CLLRGKIYDALDNRT HHHHCCHHHHCCCCE | 9.92 | 29496907 | |
| 153 (in isoform 3) | Ubiquitination | - | 11.48 | 21890473 | |
| 153 (in isoform 2) | Ubiquitination | - | 11.48 | 21890473 | |
| 154 (in isoform 1) | Ubiquitination | - | 30.48 | 21890473 | |
| 154 | Ubiquitination | TLATYSYKEALKLDV EEEEECHHHHHCCCE | 30.48 | 21890473 | |
| 192 | Ubiquitination | LESLPLSKLCNEEQE HHHCCHHHHCCHHHH | 65.82 | - | |
| 208 | Ubiquitination | LRFLFENKLKKYNKP HHHHHHHHHHHCCCC | 55.26 | - | |
| 212 | Phosphorylation | FENKLKKYNKPSETV HHHHHHHCCCCCCCC | 27.17 | 29759185 | |
| 216 | Phosphorylation | LKKYNKPSETVIPES HHHCCCCCCCCCCCC | 47.73 | 29759185 | |
| 218 | Phosphorylation | KYNKPSETVIPESVD HCCCCCCCCCCCCCC | 28.24 | 29759185 | |
| 248 | Ubiquitination | HYYNCDFKMCYKLTS HHHCCCHHHEEECHH | 18.14 | - | |
| 254 | Phosphorylation | FKMCYKLTSVVMEKD HHHEEECHHHHHHCC | 18.47 | 21406692 | |
| 255 | Phosphorylation | KMCYKLTSVVMEKDP HHEEECHHHHHHCCC | 24.13 | 21406692 | |
| 260 | Ubiquitination | LTSVVMEKDPFHASC CHHHHHHCCCCCCCC | 53.24 | - | |
| 322 | Phosphorylation | KNEHARRYLSKATTL CCHHHHHHHHHCCCC | 15.13 | 30177828 | |
| 324 | Phosphorylation | EHARRYLSKATTLEK HHHHHHHHHCCCCCC | 16.00 | 21712546 | |
| 325 | Ubiquitination | HARRYLSKATTLEKT HHHHHHHHCCCCCCC | 47.35 | - | |
| 327 | Phosphorylation | RRYLSKATTLEKTYG HHHHHHCCCCCCCCC | 35.33 | 21712546 | |
| 328 | Phosphorylation | RYLSKATTLEKTYGP HHHHHCCCCCCCCCC | 37.47 | 21712546 | |
| 329 | Ubiquitination | YLSKATTLEKTYGPA HHHHCCCCCCCCCCC | 5.73 | 21890473 | |
| 396 | Phosphorylation | RFFSQALSIAPEDPF HHHHHHHHCCCCCCC | 21.51 | - | |
| 420 | Phosphorylation | FQNGEWKTAEKWFLD EECCCEEHHHHHHHH | 40.91 | - | |
| 422 (in isoform 2) | Ubiquitination | - | 56.93 | 21890473 | |
| 423 (in isoform 1) | Ubiquitination | - | 40.56 | 21890473 | |
| 423 | Ubiquitination | GEWKTAEKWFLDALE CCEEHHHHHHHHHHH | 40.56 | 21890473 | |
| 433 | Ubiquitination | LDALEKIKAIGNEVT HHHHHHHHHHCCCCC | 45.05 | - | |
| 440 | Phosphorylation | KAIGNEVTVDKWEPL HHHCCCCCCCCHHHH | 19.46 | - | |
| 443 | Ubiquitination | GNEVTVDKWEPLLNN CCCCCCCCHHHHHHH | 49.47 | - | |
| 460 | Ubiquitination | HVCRKLKKYAEALDY HHHHHHHHHHHHHHH | 61.19 | - | |
| 462 | Ubiquitination | CRKLKKYAEALDYHR HHHHHHHHHHHHHHH | 12.41 | 21890473 | |
| 478 | Ubiquitination | ALVLIPQNASTYSAI EEEEECCCCCHHHHH | 30.42 | 21890473 | |
| 490 | Phosphorylation | SAIGYIHSLMGNFEN HHHHHHHHHHCCHHH | 15.53 | 22817900 | |
| 504 (in isoform 3) | Ubiquitination | - | 17.43 | 21890473 | |
| 520 (in isoform 3) | Ubiquitination | - | 11.64 | 21890473 | |
| 553 | Ubiquitination | DFDVHTMKTLKNIIS CCCHHHHHHHHHHCC | 52.43 | - | |
| 555 (in isoform 2) | Ubiquitination | - | 3.14 | 21890473 | |
| 556 | Ubiquitination | VHTMKTLKNIISPPW HHHHHHHHHHCCCCC | 51.86 | 21890473 | |
| 556 (in isoform 1) | Ubiquitination | - | 51.86 | 21890473 | |
| 560 | Phosphorylation | KTLKNIISPPWDFRE HHHHHHCCCCCCHHH | 22.55 | 22167270 | |
| 571 (in isoform 2) | Ubiquitination | - | 32.05 | 21890473 | |
| 572 | Ubiquitination | FREFEVEKQTAEETG HHHHCCCHHHHHHHC | 59.11 | 2190698 | |
| 572 (in isoform 1) | Ubiquitination | - | 59.11 | 21890473 | |
| 574 | Phosphorylation | EFEVEKQTAEETGLT HHCCCHHHHHHHCCC | 47.29 | 21406692 | |
| 578 | Phosphorylation | EKQTAEETGLTPLET CHHHHHHHCCCCCCC | 29.06 | 26657352 | |
| 581 | Phosphorylation | TAEETGLTPLETSRK HHHHHCCCCCCCCCC | 27.46 | 29255136 | |
| 585 | Phosphorylation | TGLTPLETSRKTPDS HCCCCCCCCCCCCCC | 41.33 | 30108239 | |
| 586 | Phosphorylation | GLTPLETSRKTPDSR CCCCCCCCCCCCCCC | 23.54 | 29255136 | |
| 589 | Phosphorylation | PLETSRKTPDSRPSL CCCCCCCCCCCCCCH | 31.08 | 26074081 | |
| 592 | Phosphorylation | TSRKTPDSRPSLEET CCCCCCCCCCCHHHH | 47.50 | 26074081 | |
| 595 | Phosphorylation | KTPDSRPSLEETFEI CCCCCCCCHHHHEEE | 47.50 | 26074081 | |
| 599 | Phosphorylation | SRPSLEETFEIEMNE CCCCHHHHEEEEECH | 19.72 | 7736578 | |
| 607 | Phosphorylation | FEIEMNESDMMLETS EEEEECHHHHEEEEC | 26.29 | 27732954 | |
| 613 | Phosphorylation | ESDMMLETSMSDHST HHHHEEEECCCCCCC | 26.26 | 27732954 | |
| 614 | Phosphorylation | SDMMLETSMSDHST- HHHEEEECCCCCCC- | 13.60 | 27732954 | |
| 616 | Phosphorylation | MMLETSMSDHST--- HEEEECCCCCCC--- | 31.75 | 27732954 | |
| 619 | Phosphorylation | ETSMSDHST------ EECCCCCCC------ | 40.58 | 27732954 | |
| 620 | Phosphorylation | TSMSDHST------- ECCCCCCC------- | 38.93 | 27732954 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 560 | S | Phosphorylation |
| 14657031 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDC16_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560 AND THR-581, ANDMASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560 AND THR-581, ANDMASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560 AND THR-581, ANDMASS SPECTROMETRY. | |
| "Mitotic regulation of the human anaphase-promoting complex byphosphorylation."; Kraft C., Herzog F., Gieffers C., Mechtler K., Hagting A., Pines J.,Peters J.-M.; EMBO J. 22:6598-6609(2003). Cited for: PHOSPHORYLATION AT SER-112; SER-490; SER-560; THR-581; SER-595 ANDTHR-599. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-581, AND MASSSPECTROMETRY. | |